Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2023-08-03 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
北京观韬中茂律师事务所关于北京康乐卫士生物技术股份有限公司2023年第九次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and procedural compliance of the convening and conduct of the 2023 ninth extraordinary general meeting (临时股东大会) of Beijing Kangle Weishi Biotechnology Co., Ltd. It details the convening procedures, attendance, voting methods, and results of the shareholder meeting. The document does not contain financial statements or financial performance data but focuses on the legal validation of the shareholder meeting and its resolutions. This type of document is a legal opinion related to a shareholder meeting and the voting results. It is not a full annual or interim report, nor an earnings release or management report. It is not a proxy solicitation or a general regulatory filing. The document essentially reports the voting results and legal compliance of the shareholder meeting. Therefore, the most appropriate classification is "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length is 4617 characters, which is sufficient to contain detailed voting results and legal opinions, not just a brief announcement. Confidence is high given the detailed voting results and legal opinion context.
2023-08-03 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Beijing Health Guard Biotechnology Inc. It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, shareholder meetings, share issuance, share transfer, capital changes, and other governance matters. It references relevant laws and regulations such as the Company Law, Securities Law, and Beijing Stock Exchange listing rules. The content is focused on the internal rules and governance framework of the company rather than financial results, audit opinions, or meeting announcements. It is a governance document that sets out the company's rules and procedures. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance provisions, confirming it is not a brief announcement or a report publication notice.
2023-08-03 Chinese
2023年第九次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions from the 2023 ninth extraordinary general meeting of shareholders of Beijing Kangle Weishi Biotechnology Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on shareholder voting outcomes and governance changes such as amendments to the company charter and governance rules. There are no financial statements or detailed financial data presented. The document is a formal announcement of voting results from a shareholder meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1875 characters), and it is not a full report but a meeting resolution announcement. Therefore, the correct classification is DVA with high confidence.
2023-08-03 Chinese
关于获得欧盟质量受权人符合性声明的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Beijing Kangle Weishi Biotechnology Co., Ltd. regarding the receipt of a Qualified Person (QP) compliance declaration following an EU GMP audit. It describes the audit process, standards, and the impact on the company, emphasizing that it does not affect current financial performance. The document is short (913 characters) and serves as a regulatory announcement about compliance and quality certification rather than a financial report or detailed audit report. It does not contain financial statements or detailed audit results but rather informs investors about the compliance status and associated risks. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-31 Chinese
关于子公司获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (792 characters) about a subsidiary receiving government subsidies. It includes details of the subsidy amounts and references accounting treatment but does not contain any financial statements or detailed financial analysis. It is an update on a specific event affecting the company, not a full financial report or earnings release. The document is an announcement of a government grant receipt, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2023-07-26 Chinese
回购股份注销完成暨股份变动公告
Transaction in Own Shares Classification · 100% confidence The document is a company announcement regarding the completion of share repurchase cancellation and the resulting changes in shareholding structure. It details the number of shares repurchased and cancelled, the shareholding percentages before and after cancellation, and mentions subsequent administrative steps. There is no financial report, earnings data, or management discussion. The content fits the description of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2023-07-26 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.